EP08.02-013 Prognostic Utility of the ALI (Advanced Lung Index) in Crizotinib-Treated ALK and ROS1Fusion-Positive NSCLC

A. Gibson, M. Dean, A.J. Elegbede, A. Pabani, G.J. Bebb, W.Y. Cheung

Journal of Thoracic Oncology(2022)

引用 0|浏览0
暂无评分
关键词
advanced lung index,nsclc,crizotinib-treated,fusion-positive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要